Company
Sun Pharm Inds INC
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
25
8 still marketed
Novel approvals
6
Approvals since 2021
1
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Leqselvi approved NovelJul 25, 2024
- Ortikos approved Jun 13, 2019
- Levulan new use Mar 6, 2018
- An-Sulfur Colloid new use OrphanAug 13, 2012
- Absorica approved May 25, 2012
- An-Sulfur Colloid new use Jul 22, 2011
- Levulan new use Mar 12, 2010
- Lac-Hydrin new use Aug 25, 2000
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (8)
Newest FDA action first.
- Absorica Isotretinoin · 2012
- Leqselvi Deuruxolitinib Phosphate · 2024
- Cis-Pyro Technetium Tc-99m Pyrophosphate Kit · 1987
- Cis-Mdp Technetium Tc-99m Medronate Kit · 1979
- Levulan Aminolevulinic Acid Hydrochloride · 1999
- Halog Halcinonide · 1977
- An-Sulfur Colloid Technetium Tc-99m Sulfur Colloid Kit · 1978
- Halog Halcinonide · 1974
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.